Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06218589 · ClinicalTrials.gov registry record · NA
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
A NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Non-Alcoholic Fatty Liver Disease (NAFLD), sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT06218589 is a NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Non-Alcoholic Fatty Liver Disease (NAFLD) that is actively recruiting participants, run by Emory University. The registered enrollment target is 200 participants, below the 711-participant average among 7 other Metabolic Dysfunction Associated Steatotic Liver Disease trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06218589, a NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Non-Alcoholic Fatty Liver Disease (NAFLD), is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Velacur
- DIAGNOSTIC_TEST Blood sample collection for biomarkers
- DIAGNOSTIC_TEST Liver biopsy
Study Locations (2)
Georgia
- Children's Healthcare of Atlanta (CHOA) - Atlanta
- Emory Children's Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06218589
The ClinicalTrials.gov registry entry for NCT06218589 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 711-participant average among 7 other Metabolic Dysfunction Associated Steatotic Liver Disease trials with a reported enrollment target (72% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metabolic Dysfunction Associated Steatotic Liver Disease appearing as the primary indexed condition, and to 4 interventions - of which MRI is the first listed.
NCT06218589 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06218589 about?
NCT06218589 is a clinical study titled "Non-Invasive Diagnostic Tests for MASLD in Pediatric Population". This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.
What is the current status of trial NCT06218589?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-01-18. Estimated completion is 2026-01-31.
What conditions does trial NCT06218589 study?
This clinical trial studies the following conditions: Metabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease (NAFLD).
What interventions are being tested in trial NCT06218589?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST), Velacur (DIAGNOSTIC_TEST), Blood sample collection for biomarkers (DIAGNOSTIC_TEST), Liver biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06218589?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06218589 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Dysfunction Associated Steatotic Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis
RECRUITING · NA
-
Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
RECRUITING · NA
-
Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
ACTIVE NOT RECRUITING · NA
-
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RECRUITING · Phase 3
-
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Metabolic Dysfunction Associated Steatotic Liver Disease
All registered trials for this condition
Non-Alcoholic Fatty Liver Disease (NAFLD)
All registered trials for this condition
Georgia
All trials with a study site in Georgia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.